Product Code: GVR-4-68040-097-9
AI in Medical Writing Market Growth & Trends
The global AI in medical writing market size is anticipated to reach USD 1.76 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 12.44% from 2023 to 2030. The primary factor driving the market expansion is the growing acceptance of machine learning, such as Artificial Intelligence(AI), in the healthcare industry. Moreover, the rising demand for reducing healthcare expenditures and increasing R&D investments by pharmaceutical companies to reduce expenses are other factors that are propelling market growth. The COVID-19 pandemic had affected the market moderately. The pandemic caused a pause in research and development activities as well as clinical trials.
Moreover, budgetary limitations led many pharmaceutical companies to reduce their investments. The initial stages of the pandemic also resulted in a decrease in submissions to healthcare journals, negatively impacting market growth. However, the significance of collaborative efforts between companies, research groups, and government bodies in the development of innovative therapies was demonstrated during the COVID-19 pandemic. Consequently, medical device, biotechnology, and life science companies have intentions to boost their investment in medical writers. Thus, increasing the demand for AI in the healthcare industry during the COVID-19 pandemic.
AI In Medical Writing Market Report Highlights
- Based on type, the typewriting segment dominated the market with a share of 32.89% of the overall revenue in 2022 due to the necessity of submitting regulatory documents to the authorities. Thus, boosting the demand for AI in medical writing in this segment
- Based on end-use, the pharmaceutical segment dominated the market with a revenue share of 33.29% in 2022.
- The high share was attributed to the heavy investments in R&D activities to develop new drugs and treatments, which augmented the demand for AI in medical writing in this end-use segment
- In 2022, North America dominated the market with a revenue share of 30.12%owing to the continuous technological advancements, increasing healthcare infrastructure, and ahigh number of drug trials & their approvals
Table of Contents
Chapter 1 AI in Medical Writing Market: Research Methodology And Scope
- 1.1 Market Segmentation and Scope
- 1.1.1 Segment Definitions
- 1.1.1.1 Type Segment
- 1.1.1.2 End-Use Segment
- 1.2 Regional Scope
- 1.3 Estimates And Forecast Timeline
- 1.4 Objectives
- 1.4.1 Objective - 1
- 1.4.2 Objective - 2
- 1.4.3 Objective - 3
- 1.5 Research Methodology
- 1.6 Information Procurement
- 1.6.1 Purchased Database
- 1.6.2 Gvr's Internal Database
- 1.6.3 Secondary Sources
- 1.6.4 Primary Research
- 1.7 Information Or Data Analysis
- 1.7.1 Data Analysis Models
- 1.8 Market Formulation & Validation
- 1.9 Model Details
- 1.9.1 Commodity Flow Analysis
- 1.10 List of Secondary Sources
- 1.11 List of Abbreviations
Chapter 2 AI in Medical Writing Market: Executive Summary
- 2.1 Market Outlook
- 2.2 Type and Product Snapshot
- 2.3 Competitive Landscape Snapshot
Chapter 3 AI in Medical Writing Market: Market Variables, Trends & Scope
- 3.1 Market Lineage Outlook
- 3.1.1 Related/Ancillary Market Outlook
- 3.2 Market Dynamics
- 3.2.1 Market Drivers Analysis
- 3.2.1.1 Rapid Technological Advancements
- 3.2.1.2 Growing Volume Of Biomedical Literature
- 3.2.1.3 Increasing Demand For Efficiency And Accuracy
- 3.2.2 Market Restraint Analysis
- 3.2.2.1 Data security and privacy issues
- 3.2.2.2 Lack of standardization
- 3.3 Industry Analysis Tools
- 3.3.1 Porter's Analysis
- 3.3.2 Pestel Analysis
Chapter 4 AI in Medical Writing Market: Type Business Analysis
- 4.1 AI in Medical Writing Market: Type Movement Analysis
- 4.2 Clinical Writing
- 4.2.1 Clinical Writing Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 4.3 Type Writing
- 4.3.1 Type Writing Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 4.4 Scientific Writing
- 4.4.1 Scientific Writing Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 4.5 Others
- 4.5.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 5 Ai In Medical Writing Market: End-Use Business Analysis
- 5.1 Ai In Medical Writing Market: End-Use Movement Analysis
- 5.2 Medical Devices
- 5.2.1 Medical Devices Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 5.3 Pharmaceutical
- 5.3.1 Pharmaceutical Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 5.4 Biotechnology
- 5.4.1 Biotechnology Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 5.5 Others
- 5.5.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 6 AI in Medical Writing Market: Regional Business Analysis
- 6.1 Regional Market Snapshot
- 6.2 North America
- 6.2.1 North America AI in Medical Writing Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 6.2.2 U.S.
- 6.2.2.1 U.S. Ai In Medical Writing Market, 2018 - 2030 (USD Million)
- 6.2.2.2 Key Country Dynamics
- 6.2.2.3 Regulatory Framework
- 6.2.2.4 Reimbursement Scenario
- 6.2.3 Canada
- 6.2.3.1 Canada AI in Medical Writing Market, 2018 - 2030 (USD Million)
- 6.2.3.2 Key Country Dynamics
- 6.2.3.3 Regulatory Framework
- 6.2.3.4 Reimbursement Scenario
- 6.3 Europe
- 6.3.1 Europe AI In Medical Writing Market, 2018 - 2030 (USD Million)
- 6.3.2 UK
- 6.3.2.1 UK AI In Medical Writing Market, 2018 - 2030 (USD Million)
- 6.3.2.2 Key Country Dynamics
- 6.3.2.3 Regulatory Framework
- 6.3.2.4 Reimbursement Scenario
- 6.3.3 Germany
- 6.3.3.1 Germany Ai In Medical Writing Market, 2018 - 2030 (USD Million)
- 6.3.3.2 Key Country Dynamics
- 6.3.3.3 Regulatory Framework
- 6.3.3.4 Reimbursement Scenario
- 6.3.4 Spain
- 6.3.4.1 Spain Ai In Medical Writing Market, 2018 - 2030 (USD Million)
- 6.3.4.2 Key Country Dynamics
- 6.3.4.3 Regulatory Framework
- 6.3.4.4 Reimbursement Scenario
- 6.3.5 France
- 6.3.5.1 France Ai In Medical Writing Market, 2018 - 2030 (USD Million)
- 6.3.5.2 Key Country Dynamics
- 6.3.5.3 Regulatory Framework
- 6.3.5.4 Reimbursement Scenario
- 6.3.6 Italy
- 6.3.6.1 Italy Ai In Medical Writing Market, 2018 - 2030 (USD Million)
- 6.3.6.2 Key Country Dynamics
- 6.3.6.3 Regulatory Framework
- 6.3.6.4 Reimbursement Scenario
- 6.3.7 Denmark
- 6.3.7.1 Denmark AI In Medical Writing Market, 2018 - 2030 (USD Million)
- 6.3.7.2 Key Country Dynamics
- 6.3.7.3 Regulatory Framework
- 6.3.7.4 Reimbursement Scenario
- 6.3.8 Sweden
- 6.3.8.1 Sweden Ai In Medical Writing Market, 2018 - 2030 (USD Million)
- 6.3.8.2 Key Country Dynamics
- 6.3.8.3 Regulatory Framework
- 6.3.8.4 Reimbursement Scenario
- 6.3.9 Norway
- 6.3.9.1 Norway Ai In Medical Writing Market, 2018 - 2030 (USD Million)
- 6.3.9.2 Key Country Dynamics
- 6.3.9.3 Regulatory Framework
- 6.3.9.4 Reimbursement Scenario
- 6.4 Asia Pacific
- 6.4.1 Asia-Pacific Ai In Medical Writing Market, 2018 - 2030 (USD Million)
- 6.4.2 Japan
- 6.4.2.1 Japan AI in Medical Writing Market, 2018 - 2030 (USD Million)
- 6.4.2.2 Key Country Dynamics
- 6.4.2.3 Regulatory Framework
- 6.4.2.4 Reimbursement Scenario
- 6.4.3 China
- 6.4.3.1 China Ai In Medical Writing Market, 2018 - 2030 (USD Million)
- 6.4.3.2 Key Country Dynamics
- 6.4.3.3 Regulatory Framework
- 6.4.3.4 Reimbursement Scenario
- 6.4.4 India
- 6.4.4.1 India Ai In Medical Writing Market, 2018 - 2030 (USD Million)
- 6.4.4.2 Key Country Dynamics
- 6.4.4.3 Regulatory Framework
- 6.4.4.4 Reimbursement Scenario
- 6.4.5 South Korea
- 6.4.5.1 South Korea Ai In Medical Writing Market, 2018 - 2030 (USD Million)
- 6.4.5.2 Key Country Dynamics
- 6.4.5.3 Regulatory Framework
- 6.4.5.4 Reimbursement Scenario
- 6.4.6 Thailand
- 6.4.6.1 Thailand Ai In Medical Writing Market, 2018 - 2030 (USD Million)
- 6.4.6.2 Key Country Dynamics
- 6.4.6.3 Regulatory Framework
- 6.4.6.4 Reimbursement Scenario
- 6.4.7 Australia
- 6.4.7.1 Australia AI in Medical Writing Market, 2018 - 2030 (USD Million)
- 6.4.7.2 Key Country Dynamics
- 6.4.7.3 Regulatory Framework
- 6.4.7.4 Reimbursement Scenario
- 6.5 Latin America
- 6.5.1 Latin America AI in Medical Writing Market, 2018 - 2030 (USD Million)
- 6.5.2 Brazil
- 6.5.2.1 Brazil Ai In Medical Writing Market, 2018 - 2030 (USD Million)
- 6.5.2.2 Key Country Dynamics
- 6.5.2.3 Regulatory Framework
- 6.5.2.4 Reimbursement Scenario
- 6.5.3 Mexico
- 6.5.3.1 Mexico Ai In Medical Writing Market, 2018 - 2030 (USD Million)
- 6.5.3.2 Key Country Dynamics
- 6.5.3.3 Regulatory Framework
- 6.5.2.4 Reimbursement Scenario
- 6.5.4 Argentina
- 6.5.4.1 Argentina AI in Medical Writing Market, 2018 - 2030 (USD Million)
- 6.5.4.2 Key Country Dynamics
- 6.5.4.3 Regulatory Framework
- 6.5.4.4 Reimbursement Scenario
- 6.6 MEA
- 6.6.1 MEA AI in Medical Writing Market, 2018 - 2030 (USD Million)
- 6.6.2 South Africa
- 6.6.2.1 South Africa Ai In Medical Writing Market, 2018 - 2030 (USD Million)
- 6.6.2.2 Key Country Dynamics
- 6.6.2.3 Regulatory Framework
- 6.6.2.4 Reimbursement Scenario
- 6.6.3 Saudi Arabia
- 6.6.3.1 Saudi Arabia Ai In Medical Writing Market, 2018 - 2030 (USD Million)
- 6.6.3.2 Key Country Dynamics
- 6.6.3.3 Regulatory Framework
- 6.4.3.4 Reimbursement Scenario
- 6.6.4 Uae
- 6.6.4.1 Uae Ai In Medical Writing Market, 2018 - 2030 (USD Million)
- 6.6.4.2 Key Country Dynamics
- 6.6.4.3 Regulatory Framework
- 6.6.2.4 Reimbursement Scenario
- 6.6.5 Kuwait
- 6.6.5.1 Kuwait AI in Medical Writing Market, 2018 - 2030 (USD Million)
- 6.6.5.2 Key Country Dynamics
- 6.6.5.3 Regulatory Framework
- 6.6.5.4 Reimbursement Scenario
Chapter 7 AI in Medical Writing Market: Competitive Landscape
- 7.1 Company Categorization
- 7.2 Strategy Mapping
- 7.2.1 New product launch
- 7.2.2 Partnerships
- 7.2.3 Acquisition
- 7.2.4 Collaboration
- 7.2.5 Funding
- 7.3 Company Market Share Analysis, 2022
- 7.4 Company Profiles
- 7.4.1 Parexel International Corporation
- 7.4.1.1 Company Overview
- 7.4.1.2 Product Benchmarking
- 7.4.1.3 Strategic Initiatives
- 7.4.2 Trilogy Writing & Consulting GmBH
- 7.4.2.1 Company Overview
- 7.4.2.2 Product Benchmarking
- 7.4.2.3 Strategic Initiatives
- 7.4.3 Freyr
- 7.4.3.1 Company Overview
- 7.4.3.2 Product Benchmarking
- 7.4.3.3 Strategic Initiatives
- 7.4.4 Cactus Communications
- 7.4.4.1 Company Overview
- 7.4.4.2 Product Benchmarking
- 7.4.4.3 Strategic Initiatives
- 7.4.5 GENINVO
- 7.4.5.1 Company Overview
- 7.4.5.2 Product Benchmarking
- 7.4.5.3 Strategic Initiatives
Chapter 8 KOL Recommendations/Analyst Perspective